ModelEdge
Adial Pharmaceuticals, Inc.
ADIL
Filing type
S-8
Filing date
Aug 27, 2026
Updated
Aug 28, 2026 ยท 2:47 PM

Filing

S-8Registration Statement for Securities to be Offered to Employees

Exhibits

EX-5.1OPINION OF BLANK ROME LLPEX-23.1CONSENT OF MARCUM LLP, FORMER INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ADIAL PHARMACEUTICALS, INCEX-23.2CONSENT OF CBIZ CPAS P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ADIAL PHARMACEUTICALS, INCEX-23.3CONSENT OF CBIZ CPAS P.C., INDEPENDENT AUDITOR FOR AZORA THERAPEUTICS, INCEX-99.1AZORA THERAPEUTICS, INC. 2017 EQUITY INCENTIVE PLANEX-99.3STOCK OPTION INDUCEMENT AWARD GRANT NOTICE AND AGREEMENT, DATED AUGUST 19, 2026, BETWEEN ADIAL PHARMACEUTICALS, INC. AND CELIA ECONOMIDESEX-FILING FEESFILING FEE TABLEGRAPHICGraphic